IRIS
PEDICA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.503
AS - Asia 2.302
NA - Nord America 1.619
SA - Sud America 376
AF - Africa 47
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.497
RU - Federazione Russa 1.409
SG - Singapore 918
CN - Cina 702
IT - Italia 476
BR - Brasile 306
HK - Hong Kong 226
VN - Vietnam 179
DE - Germania 129
FR - Francia 112
GB - Regno Unito 84
BD - Bangladesh 80
CA - Canada 64
FI - Finlandia 62
IN - India 55
SE - Svezia 55
NL - Olanda 40
MX - Messico 39
PL - Polonia 32
AT - Austria 31
AR - Argentina 26
JP - Giappone 25
TR - Turchia 17
ES - Italia 15
IQ - Iraq 15
ZA - Sudafrica 14
EC - Ecuador 12
IE - Irlanda 10
ID - Indonesia 9
LT - Lituania 9
PK - Pakistan 9
UZ - Uzbekistan 8
BE - Belgio 7
CH - Svizzera 7
VE - Venezuela 7
MA - Marocco 6
MY - Malesia 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
JM - Giamaica 5
KE - Kenya 5
TH - Thailandia 5
TN - Tunisia 5
TW - Taiwan 5
UA - Ucraina 5
UY - Uruguay 5
AO - Angola 4
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
NI - Nicaragua 4
PE - Perù 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
AU - Australia 3
GH - Ghana 3
IR - Iran 3
KR - Corea 3
NP - Nepal 3
PH - Filippine 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
CY - Cipro 2
IL - Israele 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
JO - Giordania 1
MK - Macedonia 1
MU - Mauritius 1
PT - Portogallo 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.852
Salva come PNG Salva come JPEG
Città #
Singapore 597
Moscow 266
Ashburn 251
San Jose 247
Hong Kong 219
Dallas 154
Milan 127
Shanghai 123
Beijing 121
Hefei 81
Lauterbourg 72
New York 70
Los Angeles 65
Ho Chi Minh City 61
Santa Clara 45
Boardman 43
Rome 43
Hanoi 36
Munich 36
Council Bluffs 35
São Paulo 31
Orem 30
Warsaw 28
Helsinki 27
London 26
Nuremberg 26
Montreal 24
Lappeenranta 22
Brooklyn 20
Frankfurt am Main 20
Tokyo 19
Vienna 19
Guangzhou 17
Mexico City 17
Toronto 17
Denver 16
Houston 16
Chennai 15
Chicago 14
Atlanta 13
Turku 13
Johannesburg 12
Seattle 12
Stockholm 12
Amsterdam 11
Ankara 11
Falkenstein 11
Lawrence 11
Poplar 11
Princeton 11
Romagnano Sesia 11
Boston 10
Cesano Boscone 9
Da Nang 9
Dublin 9
Genoa 9
San Francisco 9
Baghdad 8
Belo Horizonte 8
Monza 8
Tashkent 8
Bexley 7
Brussels 7
Cagliari 7
Haiphong 7
Mugnano di Napoli 7
Philadelphia 7
Phoenix 7
Rio de Janeiro 7
Shenzhen 7
Trento 7
Xi'an 7
Bergamo 6
Bologna 6
Buffalo 6
Dhaka 6
Guarulhos 6
Jiaxing 6
Manchester 6
Paris 6
Parma 6
Turin 6
City of London 5
Gatchina 5
Mumbai 5
Nairobi 5
New Delhi 5
Ottawa 5
Porto Alegre 5
Rho 5
Asunción 4
Bari 4
Barnet 4
Casablanca 4
Changsha 4
Charlotte 4
Copenhagen 4
Florence 4
Harbin 4
Hyderabad 4
Totale 3.539
Salva come PNG Salva come JPEG
Nome #
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 189
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 178
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger? 173
Pathology and molecular pathology of cholangiocarcinoma 142
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib 133
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 129
Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging 126
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 125
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 116
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 112
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 110
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 109
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 107
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 107
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 105
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 103
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 103
Association of IgG4-related disease and systemic rheumatic disorders 102
Gene-Based Immune Reprogramming Overcomes the Immunosuppressive Microenvironment of Liver Metastases and Enables Protective T Cell Responses 101
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 100
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 100
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 100
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 100
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome 98
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 97
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 95
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 93
A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse 93
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 91
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions 90
Cholangiocarcinoma: new perspectives for new horizons 88
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 88
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 87
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 87
Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos 86
The real life of precision medicine in biliary tract cancers: a tertiary referral centre experience 86
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime 85
HCC in metabolic syndrome: current concepts and future directions 84
Minimally Invasive Approach Provides Oncological Benefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for Intrahepatic Cholangiocarcinoma (iCCA) 84
Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies 84
Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution 83
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] 81
IFNalpha by In Vivo-Engineered Macrophages Abates Liver Metastases and Triggers Counter Regulatory Responses Limiting Efficacy 81
The oncologic burden of residual disease in incidental gallbladder cancer: An elastic net regression model to profile high-risk features 80
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming 80
Subcutaneous dirofilariosis in Italy: a diagnostic hypothesis to remind when the anamnesis is misleading 80
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection 78
Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report 78
IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy 76
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations 74
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 73
Age influence on mice lung tissue response to Aspergillus fumigatus chronic exposure 72
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 71
Repeated administration of the food additive E171 to mice results in accumulation in intestine and liver and promotes an inflammatory status 70
Clinicopathological features of adenosquamous pancreatic cancer 69
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 68
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination 68
Pure and mixed gallbladder neuroendocrine neoplasms: rare and orphan lesions 66
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 66
Late Breaking Abstract - Morphological and immunophenotypical features of lung tissue in early phase of COVID-19 66
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease 64
Mucinous cystic neoplasms of the liver: A clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct 62
PDX-1 (Pancreatic/Duodenal Homeobox-1 Protein 1) 60
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis. 59
Hydroxyapatite/collagen composite is a reliable material for malar augmentation 57
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 56
Lymphangiogenesis in Crohn's disease: An immunohistochemical study using monoclonal antibody D2-40 55
Peribiliary glands pathology in a large series of end-stage alcohol-related liver disease 55
IgG4-related autoimmune liver disease 54
Endocrine neoplasms of the pancreas: pathologic and genetic features. 54
Heterogeneity of response and immune system activity during treatment with nivolumab in hepatocellular carcinoma: Results from a single-institution retrospective analysis 54
Total portal vein replacement with peritoneal interposition graft during Whipple’s procedure for extrahepatic cholangiocarcinoma: a technical report 53
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 53
Paraoxonase-1 status in patients with hereditary hemochromatosis 51
Programmed death 1 (PD-1) and its ligand (PD-L1) as a new frontier in cancer Immunotherapy and challenges for the Pathologist: State of the art 50
Preliminary results of the influence of the in vivo use of a lymphatic dye (Patent Blue V) in the surgical treatment of Crohn's disease 49
Massive retinal gliosis in a young woman with congenital toxoplasmosis 48
Toxicity profile of adjuvant hypofractionated Image-Guided Radiotherapy in biliary tract carcinoma 47
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes 46
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma 46
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? 41
Radial and Longitudinal Margins in Surgery of Perihilar Cholangiocarcinoma: When R1 Definition Is Associated with Different Prognosis 40
Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: A case report and review of the literature 40
Surgery for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: milestone changes in the last two decades potentially affecting current guidelines 39
Next-generation histopathologic diagnosis: A lesson from a hepatic carcinosarcoma 37
A viable human lung cancer tissue collection (LCTC) to accelerate translational research 7
How to approach indeterminate biliary stenosis 3
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience 2
Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature 2
Totale 7.050
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 2 3 0 2 2 1 1 2 0 1
2022/202382 25 16 9 0 1 15 5 4 7 0 0 0
2023/2024449 11 65 50 41 20 33 19 42 4 18 64 82
2024/20251.507 169 41 63 69 85 117 260 177 170 86 112 158
2025/20264.991 356 308 221 628 603 183 452 386 1.302 255 150 147
Totale 7.050